Monday, September 14, 2026

ABL206: First-in-Class Dual Antibody Drug Conjugate Approved for Clinical Trials in the U.S. – What This Means for Cancer Treatment

ABL Bio and Neok Bio received FDA approval for ABL206, a dual-antibody ADC, marking a key milestone in their clinical development efforts.

Samsung to Establish Think Tank Office in Tokyo, Second Overseas Base After Beijing

Samsung Global Research plans to open a new office in Tokyo, focusing on Japan's economy, AI, and IT sectors.

Kim Claims Economic Milestones Despite Sanctions Pressure

North Korea's 9th Workers' Party Congress highlights achievements and future goals, emphasizing self-reliance and international status under Kim Jong Un.

Tag: ComplexCon

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.